Results 21 to 30 of about 39,808 (354)

Helping patients discuss CINV management : development of a patient charter [PDF]

open access: yes, 2013
In April 2012, an Expert Group of specialist cancer nurses working in a variety of settings (e.g. chemotherapy delivery, chemotherapy service design, research, nurse leadership and patient information/advocacy) participated in telephone/web-based ...
Dielenseger, Pascale   +9 more
core   +1 more source

Comparison of P6 Acupoint Stimulation, Ondansetron and Dexamethasone for Prevention of Postoperative Nausea and Vomiting after Laparoscopic Surgeries: A Randomised Clinical Study [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2023
Introduction: Non pharmacological techniques have an established role in treatment of chronic pain and related conditions. A few non pharmacological techniques have been employed to avoid the adverse effects of drugs. They have also proven to be cost-
Krishnaraj Nivatha   +3 more
doaj   +1 more source

Efficacy of Gabapentin versus Combination of Dexamethasone-Ondansetron in Prevention of Postoperative Nausea and Vomiting in Middle Ear Surgery: A Randomised Clinical Study [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2023
Introduction: Postoperative Nausea and Vomiting (PONV) is the most common and unpleasant complication with incidence of 30-80% after elective surgery. Dexamethasone and Ondansetron (DO) combination has superior efficacy and is recommended as an ideal
Usha R Sastry   +5 more
doaj   +1 more source

Bimodal release ondansetron for acute gastroenteritis among adolescents and adults: A randomized clinical trial [PDF]

open access: yes, 2019
Importance: Vomiting resulting from acute gastroenteritis is commonly treated with intravenous antiemetics in acute care settings. If oral treatment were beneficial, patients might not need intravenous administered hydration or medication. Furthermore, a
Avarello, Jahn   +11 more
core   +2 more sources

Hyperemesis gravidarum in the primary care setting: cross-sectional study of GPs

open access: yesBJGP Open, 2022
Background: Hyperemesis gravidarum (HG), if untreated, can lead to malnutrition, dehydration, and Wernicke’s encephalopathy. Foetal complications include low birth weight and neurodevelopmental delay.
Melanie Nana   +3 more
doaj   +1 more source

Update on medication-overuse headache and its treatment [PDF]

open access: yes, 2015
OPINION STATEMENT: Medication-overuse headache-i.e., a too-frequent consumption of acute headache medications leading to increased headache frequency and reduced effectiveness of acute and preventive treatments-is a serious medical condition whose ...
Giamberardino MA   +2 more
core   +1 more source

Costs Associated with Malaria in Pregnancy in the Brazilian Amazon, a Low Endemic Area Where Plasmodium vivax Predominates. [PDF]

open access: yes, 2016
BACKGROUND: Information on costs associated with malaria in pregnancy (MiP) in low transmission areas where Plasmodium vivax predominates is so far missing. This study estimates health system and patient costs of MiP in the Brazilian Amazon.
Bardají, A   +7 more
core   +4 more sources

Tapentadol extended release for the management of chronic neck pain [PDF]

open access: yes, 2017
BACKGROUND: The role of opioids in the management of chronic neck pain is still poorly investigated. No data are available on tapentadol extended release (ER).
Coluzzi, Flaminia
core   +1 more source

Reye Syndrome and Anti-Emetics

open access: yesPediatric Neurology Briefs, 1991
A drug-induced encephalopathy mainly by anti-emetics in two children with a diagnosis of Reye syndrome is reported from the Department of Paediatrics, University Hospital, Gasthuisberg, Leuven, Belgium.
J Gordon Millichap
doaj   +1 more source

Comparative Study of an Ondansetron and a Ramosetron an Aprepitant in the Control of Nausea and Vomiting in Gynecologinc Cancer Patient with Chemotherapy [PDF]

open access: yesKosin Medical Journal, 2013
ResultsThe efficacy of controlling nausea with an ondansetron regimen and a ramosetron regimen and an aprepitant regimen was 85.29%, 78.26%, 80% in acute periods (P-value = 0.037) and 88.23%, 98.26%, 87.5% in delayed periods (P-value = 0.000 ...
HANGGOO Yun, Heung Yeol Kim, Eun ae Jeh
doaj   +1 more source

Home - About - Disclaimer - Privacy